Literature DB >> 19949644

Pulmonary vein isolation: do all roads lead to Rome?

T A Simmers1.   

Abstract

Year:  2009        PMID： 19949644      PMCID： PMC2773026          DOI： 10.1007/bf03086285

Source DB:  PubMed          Journal:  Neth Heart J        ISSN： 1568-5888            Impact factor:   2.380


× No keyword cloud information.
  14 in total

1.  Perception of atrial fibrillation before and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence.

Authors:  Gerhard Hindricks; Christopher Piorkowski; Hildegard Tanner; Richard Kobza; Jin-Hong Gerds-Li; Corrado Carbucicchio; Hans Kottkamp
Journal:  Circulation       Date:  2005-07-11       Impact factor: 29.690

2.  Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial.

Authors:  Oussama M Wazni; Nassir F Marrouche; David O Martin; Atul Verma; Mandeep Bhargava; Walid Saliba; Dianna Bash; Robert Schweikert; Johannes Brachmann; Jens Gunther; Klaus Gutleben; Ennio Pisano; Dominico Potenza; Raffaele Fanelli; Antonio Raviele; Sakis Themistoclakis; Antonio Rossillo; Aldo Bonso; Andrea Natale
Journal:  JAMA       Date:  2005-06-01       Impact factor: 56.272

3.  Role of transtelephonic electrocardiographic monitoring in detecting short-term arrhythmia recurrences after radiofrequency ablation in patients with atrial fibrillation.

Authors:  Gaetano Senatore; Giuseppe Stabile; Emanuele Bertaglia; Giovanni Donnici; Antonio De Simone; Franco Zoppo; Pietro Turco; Pietro Pascotto; Massimo Fazzari
Journal:  J Am Coll Cardiol       Date:  2005-03-15       Impact factor: 24.094

4.  Recurrence of atrial fibrillation correlates with the extent of post-procedural late gadolinium enhancement: a pilot study.

Authors:  Dana C Peters; John V Wylie; Thomas H Hauser; Reza Nezafat; Yuchi Han; Jeong Joo Woo; Jason Taclas; Kraig V Kissinger; Beth Goddu; Mark E Josephson; Warren J Manning
Journal:  JACC Cardiovasc Imaging       Date:  2009-03

5.  Predictive factors of sustained sinus rhythm and recurrent atrial fibrillation after a radiofrequency modified Maze procedure.

Authors:  Willem P Beukema; Hauw T Sie; Anand R Ramdat Misier; Peter Paul Delnoy; Hein J J Wellens; Arif Elvan
Journal:  Eur J Cardiothorac Surg       Date:  2008-09-02       Impact factor: 4.191

6.  Complete isolation of left atrium surrounding the pulmonary veins: new insights from the double-Lasso technique in paroxysmal atrial fibrillation.

Authors:  Feifan Ouyang; Dietmar Bänsch; Sabine Ernst; Anselm Schaumann; Hitoshi Hachiya; Minglong Chen; Julian Chun; Peter Falk; Afsaneh Khanedani; Matthias Antz; Karl-Heinz Kuck
Journal:  Circulation       Date:  2004-10-04       Impact factor: 29.690

7.  Preoperative atrial size predicts the success of radiofrequency maze procedure for permanent atrial fibrillation in patients undergoing concomitant valvular surgery.

Authors:  Mien-Cheng Chen; Jen-Ping Chang; Hsueh-Wen Chang
Journal:  Chest       Date:  2004-06       Impact factor: 9.410

8.  Early identification and treatment of PV re-connections: role of observation time and impact on clinical results of atrial fibrillation ablation.

Authors:  Xin-hua Wang; Xu Liu; Yu-min Sun; Jia-ning Gu; Hai-feng Shi; Li Zhou; Wei Hu
Journal:  Europace       Date:  2007-05-23       Impact factor: 5.214

9.  Clinical predictors and relationship between early and late atrial tachyarrhythmias after pulmonary vein antrum isolation.

Authors:  Sakis Themistoclakis; Robert A Schweikert; Walid I Saliba; Aldo Bonso; Antonio Rossillo; Giovanni Bader; Oussama Wazni; David J Burkhardt; Antonio Raviele; Andrea Natale
Journal:  Heart Rhythm       Date:  2008-01-30       Impact factor: 6.343

10.  Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study.

Authors:  Pierre Jaïs; Bruno Cauchemez; Laurent Macle; Emile Daoud; Paul Khairy; Rajesh Subbiah; Mélèze Hocini; Fabrice Extramiana; Fréderic Sacher; Pierre Bordachar; George Klein; Rukshen Weerasooriya; Jacques Clémenty; Michel Haïssaguerre
Journal:  Circulation       Date:  2008-11-24       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.